|
1
|
Park J, Kang IK, Bae JS, Kim JS and Kim K:
Clinical significance of the lymph node ratio of the second
operation to predict Re-recurrence in thyroid carcinoma. Cancers
(Basel). 15:6242023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dunlap Q and Davies L: Differentiated
Thyroid Cancer Incidence. Surgery of the Thyroid and Parathyroid
Glands. Randolph GW: 3rd Edition. Elsevier; Philadelphia, PA: pp.
174–180. 2021, View Article : Google Scholar
|
|
3
|
Alzahrani AS: The risk of expanding risk
stratification in thyroid cancer. J Clin Endocrinol Metab.
108:e1147–e1148. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nabhan F, Dedhia PH and Ringel MD: Thyroid
cancer, recent advances in diagnosis and therapy. Int J Cancer.
149:984–992. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lieberman L and Worden F: Novel
therapeutics for advanced differentiated thyroid cancer. Endocrinol
Metab Clin North Am. 51:367–378. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haymart MR: Progress and challenges in
thyroid cancer management. Endocr Pract. 27:1260–1263. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grimm D: Recent advances in thyroid cancer
research. Int J Mol Sci. 23:46312022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Santarpia L, El-Naggar AK, Cote GJ, Myers
JN and Sherman SI: PI3K/Akt and Ras/Raf-MAPK pathway mutations in
anaplastic thyroid cancer. JCEM. 93:278–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nikiforov YE and Nikiforova MN: Molecular
genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol.
7:569–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gulfidan G, Soylu M, Demirel D, Erdonmez
HBC, Beklen H, Sarica PO, Arga KY and Turanli B: Systems biomarkers
for papillary thyroid cancer prognosis and treatment through
multi-omics networks. Arch Bioch Biophysics. 715:1090852021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beck AC, Rajan A, Landers S, Kelley S and
Weigel RJ, Bellizzi AM, Lal G, Sugg SL, Howe JR, Chan CH and Weigel
RJ: Expression of cancer stem cell markers in tall cell variant
papillary thyroid cancer identifies a molecular profile predictive
of recurrence in classic papillary thyroid cancer. Surgery.
171:245–251. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Du J, Xiang Y, Liu H, Liu S, Kumar A, Xing
C and Wang Z: RIPK1 dephosphorylation and kinase activation by
PPP1R3G/PP1γ promote apoptosis and necroptosis. Nat Commun.
12:70672021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Xu D, Huang H, Chen S, Wang L,
Zhu L, Jiang X, Ruan X, Luo X, Cao P, et al: Regulation of glucose
homeostasis and lipid metabolism by PPP1R3G-mediated hepatic
glycogenesis. Mol Endocrinol. 28:116–126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du J, Xiang Y, Liu H, Liu S, Kumar A, Xing
C and Wang Z: RIPK1 dephosphorylation and kinase activation by
PPP1R3G/PP1γ promote apoptosis and necroptosis. Nat Commun.
12:70672021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Israelian L, Nitschke S, Wang P, Zhao X,
Perri AM, Lee JPY, Verhalen B, Nitschke F and Minassian BA: Ppp1r3d
deficiency preferentially inhibits neuronal and cardiac Lafora body
formation in a mouse model of the fatal epilepsy Lafora disease. J
Neurochem. 157:1897–1910. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Gu J, Wang L, Zhao Z, Pan Y and
Chen Y: Ablation of PPP1R3G reduces glycogen deposition and
mitigates high-fat diet induced obesity. Mol Cell Endocrinol.
439:133–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhuo X, Chen L, Lai Z, Liu J, Li S, Hu A
and Lin Y: Protein phosphatase 1 regulatory subunit 3G (PPP1R3G)
correlates with poor prognosis and immune infiltration in lung
adenocarcinoma. Bioengineered. 12:8336–8346. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dobin A and Gingeras TR: Mapping RNA-seq
Reads with STAR. Curr Protoc Bioinformatics. 51:112015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim K, Kim JH, Park IS, Rho YS, Kwon GH
and Lee DJ: The updated AJCC/TNM staging system for papillary
thyroid cancer (8th Edition): From the perspective of genomic
analysis. World J Surg. 42:3624–3631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Meng X, Wang P, Luan C and Wang
H: Bioinformatics analysis for the identification of
Sprouty-related EVH1 domain-containing protein 3 expression and its
clinical significance in thyroid carcinoma. Sci Rep. 14:45492024.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shibata MA and Taniguchi K: Metastasis
Inhibition. Int J Mol Sci. 24:71232023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu X, Peng N, Qi F, Li J, Shi L and Chen
R: Cigarette smoke upregulates SPRR3 by favoring c-Jun/Fra1
heterodimerization in human bronchial epithelial cells. Future
Oncol. 14:2599–2613. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sasahira T, Kurihara-Shimomura M,
Shimomura H, Bosserhoff AK and Kirita T: Identification of oral
squamous cell carcinoma markers MUC2 and SPRR1B downstream of
TANGO. J Cancer Res Clin Oncol. 147:1659–1672. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song Y, Pan H, Yang L, Fan Y, Zhang H, Pan
M and Zhang Y: DGUOK-AS1 promotes cervical squamous cell carcinoma
progression by suppressing miR-499a-5p that targets SPRR1B in
vitro. Biochem Biophys Res Commun. 585:177–184. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de AST, Souza-Santos PT, de Oliveira DS,
Bernardo V, Lima SC, Rapozo DC, Kruel CD, Faria PA, Ribeiro Pinto
LF and Albano RM: Quantitative evaluation of SPRR3 expression in
esophageal squamous cell carcinoma by qPCR and its potential use as
a biomarker. Exp Mol Pathol. 91:584–589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Naoum GE, Morkos M, Kim B and Arafat W:
Novel targeted therapies and immunotherapy for advanced thyroid
cancers. Mol Cancer. 17:512018. View Article : Google Scholar : PubMed/NCBI
|
